CA1224172A - Human endogenous cancer regulatory factor, process for preparing the same, pharmaceutical composition containing the same and human monocytic leukemia cell lines - Google Patents

Human endogenous cancer regulatory factor, process for preparing the same, pharmaceutical composition containing the same and human monocytic leukemia cell lines

Info

Publication number
CA1224172A
CA1224172A CA000445054A CA445054A CA1224172A CA 1224172 A CA1224172 A CA 1224172A CA 000445054 A CA000445054 A CA 000445054A CA 445054 A CA445054 A CA 445054A CA 1224172 A CA1224172 A CA 1224172A
Authority
CA
Canada
Prior art keywords
produced
regulatory factor
human
endogenous cancer
human endogenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000445054A
Other languages
English (en)
French (fr)
Inventor
Tadashi Obara
Hisanori Ezoe
Katsuyuki Haranaka
Nobuko Satomi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of CA1224172A publication Critical patent/CA1224172A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA000445054A 1983-07-14 1984-01-11 Human endogenous cancer regulatory factor, process for preparing the same, pharmaceutical composition containing the same and human monocytic leukemia cell lines Expired CA1224172A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP128893/1983 1983-07-14
JP58128893A JPS6019720A (ja) 1983-07-14 1983-07-14 ヒト内来性癌制御因子およびその製造法

Publications (1)

Publication Number Publication Date
CA1224172A true CA1224172A (en) 1987-07-14

Family

ID=14995948

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000445054A Expired CA1224172A (en) 1983-07-14 1984-01-11 Human endogenous cancer regulatory factor, process for preparing the same, pharmaceutical composition containing the same and human monocytic leukemia cell lines

Country Status (7)

Country Link
EP (1) EP0134923A3 (enExample)
JP (1) JPS6019720A (enExample)
CA (1) CA1224172A (enExample)
DK (1) DK607683D0 (enExample)
ES (1) ES8601705A1 (enExample)
GR (1) GR81438B (enExample)
PH (1) PH22226A (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524026A (en) * 1983-08-29 1985-06-18 Yoshio Sakagami Novel proteinous cancer-cell proliferation inhibitory factors
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
US5198428A (en) * 1991-04-05 1993-03-30 Board Of Regents, The Univ. Of Texas System Macrophage cytotoxin compositions and methods of preparation
DE4124758A1 (de) * 1991-07-25 1993-01-28 Max Planck Gesellschaft Antitumorwirksame substanz aus humanen makrophagen
WO2007124766A1 (en) * 2006-04-28 2007-11-08 Telefonaktiebolaget Lm Ericsson (Publ) Method and device for coupling cancellation of closely spaced antennas

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8204382L (sv) * 1981-07-21 1983-01-22 Hayashibara Biochem Lab Sett att framstella malcellysfaktor och anvendning derav

Also Published As

Publication number Publication date
GR81438B (enExample) 1984-12-11
JPS6019720A (ja) 1985-01-31
DK607683D0 (da) 1983-12-30
EP0134923A2 (en) 1985-03-27
ES528971A0 (es) 1985-07-01
PH22226A (en) 1988-07-01
ES8601705A1 (es) 1985-07-01
EP0134923A3 (en) 1986-12-03

Similar Documents

Publication Publication Date Title
Granger et al. Production of lymphotoxin and migration inhibitory factor by established human lymphocytic cell lines
Nelson et al. A membrane-cytoskeletal complex containing Na+, K+-ATPase, ankyrin, and fodrin in Madin-Darby canine kidney (MDCK) cells: implications for the biogenesis of epithelial cell polarity.
Papageorgiou et al. Production and characterization of migration inhibitory factor (s)(MIF) of established lymphoid and non-lymphoid cell lines
Yron et al. In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.
Kay et al. Polypeptides immunologically related to band 3 are present in nucleated somatic cells.
Khar Development and characterization of a rat histiocyte-macrophage tumor line
EP0061141B1 (en) Chemokinesins and chemotaxins of leukocytes and inflamed tissues: natural mediator proteins for reversible promotion of random and directional locomotion (chemokinesis and chemotaxis) for accumulation of specific leukocyte types, process of their biotechnical preparation and pharmaceutical compositions
GB2121417A (en) Antigens and antibodies useful in the detection of cancer
US5643740A (en) Monoclonal antibody specific for activated lymphocytes and monocytes
EP0134923A2 (en) Process for preparing a human endogenous cancer regulatory factor, pharmaceutical composition containing the same, and human monocytic leukemia cell lines
Papageorgiou et al. Similarity of migration inhibitory factor (s) produced by human lymphoid cell line and phytohemagglutinin and tuberculin-stimulated human peripheral lymphocytes
EP0363703B1 (en) Method of producing human-human hybridomas, the production of monoclonal and polyclonal antibodies therefrom, and therapeutic use thereof
US5330896A (en) Monoclonal antibodies to an autocrine growth factor antigen that binds to activated lymphocytes and cancer cells
Machii et al. Similarities between IgG-bearing lymphocytes and hairy cells: cytologic and cytochemical studies
Primi et al. A hemolytic plaque assay for activated murine T cells.
Slayter et al. Electron microscopy and physical parameters of human blood group i, A, B, and H antigens
Claesson et al. Colony formation by subpopulations of human T lymphocytes. I. Effects of phytohaemagglutinin and lymphocytosis-promoting factor from Bordetella pertussis
US5348880A (en) Tumor associated monoclonal antibody 81AV/78
WO1990007525A1 (en) Keratoconjunctivitis cytotoxin and methods for its use and production
AU630873B2 (en) Lung growth stimulatory and inhibitory factors for carcinoma tumor cells
Griffin et al. A Human Lymphokine Activates Macrophage C3 Receptors for Phagocytosis: Studies Using Monoclonal Anti‐Lymphokine Antibodies
EP0311438B1 (en) Antigen capable of binding to cancer cells
JPS60208924A (ja) ヒト腫瘍壊死因子に対する抗体
Desimone et al. The Xenopus Embryo as a Model System for the Study of Cell—Extracellular Matrix Interactions
EP0234545A2 (en) Purified human angiogenic factor, method for its preparation and pharmaceutical preparations

Legal Events

Date Code Title Description
MKEX Expiry